CBS 2019
CBSMD教育中心
中 文

充血性心力衰竭

Abstract

Recommended Article

Rationale and design of the GUIDE-IT study: Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure Sex Differences in Heart Failure With Preserved Ejection Fraction Pathophysiology: A Detailed Invasive Hemodynamic and Echocardiographic Analysis Frequency, predictors, and prognosis of ejection fraction improvement in heart failure: an echocardiogram-based registry study Heart Failure With Mid-Range (Borderline) Ejection Fraction: Clinical Implications and Future Directions Rationale and design of the comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode (PIONEER-HF) trial The Hospital Readmissions Reduction Program Nationwide Perspectives and Recommendations: A JACC: Heart Failure Position Paper Guideline‐Directed Medical Therapy for Patients With Heart Failure With Midrange Ejection Fraction: A Patient‐Pooled Analysis From the KorHF and KorAHF Registries

Original Research2018 Apr;198:145-151.

JOURNAL:Am J Cardiol. Article Link

Rationale and design of the comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode (PIONEER-HF) trial

Velazquez EJ, Morrow DA, DeVore AD et al. Keywords: sacubitril; valsartan; enalapril; NT-proBNP; acute Heart Failure episode

FULL TEXT PDF